Phoenix Biotech Acquisition Corporation (PBAX) Merger with CERo Therapeutics (Private)
June 7, 2023 Redemption Rate 50% from current level of 92.6% Share Price $10.0 per share Enterprise Value $112 million Market Cap Value $145 million Cash in Trust Less: Redemptions Add: PIPE Financing Less: Target Expenses Less: SPAC Expenses *Denotes estimated figures by CPC #Reported as on 31st March 2023